Document Type

Article

Publication Date

2018

Abstract

This short reflection on an article by J. J. Arias, A. M. Tyler, B. J. Oster, and J. Karlawish (“The Proactive Patient: Long-term Care Insurance Discrimination Risk of Alzheimer’s Disease Biomarkers,” Journal of Law, Medicine & Ethics 46, no. 2 (2018): 485-498) makes clear why the private market for long-term care insurance, and its regulation, will perpetually fail to protect families against the risks to their security posed by a family member with Alzheimer’s. It describes why a comprehensive federal solution is the only feasible and wise option.

Publication Citation

46 J. L. Med. & Ethics 499 (2018)

Share

COinS